Posted Dec. 13, 2011 at 12:52 p.m.

Premium Lock Liquidia to pursue new pneumonia vaccine

Published: 2011-12-13 12:52:15
Updated: 2011-12-13 12:52:15

Print this blog post
Liquidia Liquidia

The Research Triangle Park-based firm is working with PATH to conduct preclinical studies on a "next generation" pneumococcal vaccine that could be more effective than existing vaccines and more efficient to produce....Copyright 2013 MedCity. All rights reserved.

Please log in or register to view WRALTechWire Insider content


To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.

 1 Year Membership - 49.99 per year. Includes FREE unlimited access to online content, archives and discounts from Insider Partners. For less than $1 a week receive more than $900 in value.

 Monthly Membership - 4.99 per month. Includes FREE unlimited access every 30 days to online content only.

 Day Pass - 0.99 per day. Includes FREE unlimited access for 24 hours to online content only.

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Jim Roberts
Entrepreneurship
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll